+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-generation Probiotics Market - Global Forecast 2026-2032- Product Image
Next-generation Probiotics Market - Global Forecast 2026-2032- Product Image
Sale

Next-generation Probiotics Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090241
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Next-generation Probiotics Market is projected to reach USD 284.50 Million in 2026. It is expected to continue growing at a CAGR of 11.79%, reaching USD 556.81 Million by 2032.

Next-generation probiotics: an evidence-led introduction

Next-generation probiotics are live biotherapeutic approaches that extend beyond conventional, widely used probiotic strains. The field includes carefully characterized microorganisms, defined microbial consortia, and microbiome-derived candidates under evaluation for targeted health applications. Development depends on strain identity, mechanism-of-action evidence, manufacturing consistency, safety assessment, and clinically meaningful endpoints.

From broad wellness claims to precision microbial interventions

The landscape is shifting toward precision, with research increasingly connecting specific microbial functions to host biology, immune regulation, metabolic pathways, and barrier integrity. Progress is also being shaped by improved sequencing, anaerobic cultivation, biobanking, formulation, and quality-control methods. Regulatory classification remains a central challenge because products may be considered foods, supplements, biological medicines, or other regulated categories depending on jurisdiction and intended claims.

Artificial intelligence strengthens discovery, design, and evidence generation

Artificial intelligence is being applied to analyze metagenomic and clinical datasets, identify candidate organisms, model microbial interactions, and prioritize experimental work. Its cumulative impact is greatest when computational predictions are linked to reproducible laboratory validation and well-designed human studies. Data quality, model interpretability, privacy, bias control, and standardized phenotype definitions remain essential safeguards against overinterpreting correlations as therapeutic evidence.

Regional insights reveal uneven infrastructure and regulatory maturity

North America is characterized by strong translational research capacity, advanced clinical development ecosystems, and active interest in microbiome-based therapeutics. Europe combines substantial academic expertise with stringent requirements for safety, quality, and health claims. Asia-Pacific benefits from deep microbial diversity, expanding biotechnology capabilities, and growing clinical research activity, while regulatory approaches vary considerably. Latin America offers important population and biodiversity resources but faces uneven access to specialized infrastructure. The Middle East is developing research and healthcare innovation capacity, particularly through institutional partnerships. Africa presents valuable microbiome diversity and high-impact public-health research opportunities, alongside persistent gaps in funding, biobanking, laboratory capacity, and trial infrastructure.

International groups shape standards, access, and collaboration

ASEAN economies can benefit from coordinated regulatory dialogue, shared biobanks, and regionally relevant clinical protocols. BRICS members bring substantial population diversity and scientific capabilities, but would gain from harmonized quality standards and interoperable data practices. The European Union provides a framework for coordinated research and regulatory alignment, while the G7 contributes advanced science, financing, and clinical-development expertise. GCC countries can accelerate adoption through healthcare modernization and cross-border infrastructure. NATO members may support resilience in biomedical supply chains, laboratory networks, and research-security practices without conflating defense priorities with clinical evidence.

Country priorities range from foundational science to clinical translation

Australia can leverage microbiome research and geographically diverse cohorts; Brazil and Mexico offer important population diversity and Latin American clinical contexts. Canada has strengths in translational research and public-sector science. China and India provide large, diverse datasets and expanding biotechnology capacity, while Japan and South Korea combine advanced life-science infrastructure with strong interest in precision health. France, Germany, Italy, Spain, and the United Kingdom contribute clinical, regulatory, and academic capabilities within distinct national frameworks. Russia retains scientific capacity but faces collaboration and access constraints. The United States remains influential in discovery, venture-backed development, clinical research, and regulatory precedent. Across all countries, reproducible manufacturing, validated biomarkers, and transparent clinical evidence are common priorities.

Prioritize validated biology, scalable quality, and credible clinical outcomes

Industry leaders should select candidates using a clear evidence hierarchy that links strain-level identity to mechanism, safety, manufacturability, and patient-relevant outcomes. They should establish controls for contamination, genetic drift, potency, stability, and batch comparability early in development. Partnerships among clinicians, microbiologists, computational scientists, regulators, and patient groups can improve trial design and endpoint selection. Leaders should also build jurisdiction-specific regulatory strategies, protect sensitive data, publish negative as well as positive findings, and avoid broad claims unsupported by controlled human evidence.

Methodology: triangulating scientific, clinical, regulatory, and geographic evidence

This executive summary uses a structured synthesis of the next-generation probiotics topic across peer-reviewed research, clinical-development principles, regulatory materials, technical standards, and publicly documented regional capabilities. Evidence is interpreted qualitatively rather than converted into market estimates or forecasts. Findings are organized by technological change, artificial-intelligence applications, geography, and international groupings, with emphasis on recurring evidence requirements: biological plausibility, safety, reproducibility, manufacturing control, and clinically relevant validation.

A disciplined path from microbiome promise to dependable health applications

Next-generation probiotics have the potential to make microbiome science more targeted and clinically actionable, but progress depends on disciplined translation rather than novelty alone. The strongest opportunities will favor candidates supported by coherent mechanisms, robust manufacturing, appropriate regulatory positioning, and reproducible human evidence. Coordinated standards, inclusive research populations, responsible artificial intelligence, and regional collaboration can help convert promising microbial biology into safe, credible, and accessible interventions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Next-generation Probiotics Market, by Strain Category
7.1. Introduction
7.2. Anaerobic Gut-Derived Bacteria
7.2.1. Faecalibacterium prausnitzii
7.2.2. Roseburia intestinalis
7.2.3. Eubacterium hallii
7.2.4. Butyricicoccus pullicaecorum
7.3. Mucus-Associated Bacteria
7.3.1. Akkermansia muciniphila
7.3.2. Bacteroides thetaiotaomicron
7.3.3. Bacteroides fragilis
7.4. Spore-Forming Bacteria
7.5. Yeast & Fungal Next-Gen Probiotics
8. Next-generation Probiotics Market, by Product Form
8.1. Introduction
8.2. Capsules
8.3. Powders
8.4. Liquids
9. Next-generation Probiotics Market, by Consumer Age
9.1. Introduction
9.2. Infants
9.3. Children
9.4. Adolescents
9.5. Adults
9.6. Geriatric
10. Next-generation Probiotics Market, by Application
10.1. Introduction
10.2. Gastrointestinal Disorders
10.2.1. Inflammatory Bowel Disease
10.2.2. Infectious Diarrhea
10.2.3. Crohn's Disease
10.3. Metabolic Disorders
10.3.1. Prediabetes
10.3.2. Non-Alcoholic Fatty Liver Disease
10.4. Immune System Modulation
10.5. Cardiovascular
10.6. Urogenital
10.7. Dermatology
10.7.1. Acne
10.7.2. Atopic Dermatitis
10.7.3. Psoriasis
10.8. Neurologic and Gut Brain Axis
10.9. Oral
10.10. Oncology
11. Next-generation Probiotics Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Next-generation Probiotics Market, by Region
12.1. Introduction
12.2. Europe
12.3. Asia-Pacific
12.4. North America
12.5. Latin America
12.6. Middle East
12.7. Africa
13. Next-generation Probiotics Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Next-generation Probiotics Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. United Kingdom
14.7. India
14.8. France
14.9. South Korea
14.10. Brazil
14.11. Italy
14.12. Australia
14.13. Canada
14.14. Spain
14.15. Mexico
14.16. Russia
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Next-generation Probiotics Market, Years Considered for the Study
FIGURE 2. Global Next-generation Probiotics Market, Research Design
FIGURE 3. Global Next-generation Probiotics Market, Research Framework
FIGURE 4. Global Next-generation Probiotics Market, Data Triangulation
FIGURE 5. Global Next-generation Probiotics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Next-generation Probiotics Market Size, by Strain Category, 2025 vs 2032 (%)
FIGURE 7. Global Next-generation Probiotics Market Size, by Strain Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Next-generation Probiotics Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 9. Global Next-generation Probiotics Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Next-generation Probiotics Market Size, by Consumer Age, 2025 vs 2032 (%)
FIGURE 11. Global Next-generation Probiotics Market Size, by Consumer Age, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Next-generation Probiotics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Next-generation Probiotics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Next-generation Probiotics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Next-generation Probiotics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Next-generation Probiotics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Next-generation Probiotics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Next-generation Probiotics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Next-generation Probiotics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Next-generation Probiotics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Next-generation Probiotics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Next-generation Probiotics Market Segmentation & Coverage
TABLE 2. Global Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 4. Global Anaerobic Gut-Derived Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anaerobic Gut-Derived Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anaerobic Gut-Derived Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Faecalibacterium prausnitzii Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Faecalibacterium prausnitzii Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Faecalibacterium prausnitzii Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Roseburia intestinalis Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Roseburia intestinalis Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Roseburia intestinalis Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Eubacterium hallii Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Eubacterium hallii Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Eubacterium hallii Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Butyricicoccus pullicaecorum Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Butyricicoccus pullicaecorum Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Butyricicoccus pullicaecorum Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Mucus-Associated Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Mucus-Associated Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Mucus-Associated Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Akkermansia muciniphila Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Akkermansia muciniphila Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Akkermansia muciniphila Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Bacteroides thetaiotaomicron Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Bacteroides thetaiotaomicron Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Bacteroides thetaiotaomicron Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Bacteroides fragilis Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Bacteroides fragilis Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Bacteroides fragilis Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Spore-Forming Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Spore-Forming Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Spore-Forming Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Yeast & Fungal Next-Gen Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Yeast & Fungal Next-Gen Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Yeast & Fungal Next-Gen Probiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 38. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 48. Global Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Children Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Adolescents Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Adolescents Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Adolescents Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Global Gastrointestinal Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Gastrointestinal Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Gastrointestinal Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Infectious Diarrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Infectious Diarrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Infectious Diarrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Crohn's Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Crohn's Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Crohn's Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Prediabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Prediabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Prediabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Non-Alcoholic Fatty Liver Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Non-Alcoholic Fatty Liver Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Non-Alcoholic Fatty Liver Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Immune System Modulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Immune System Modulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Immune System Modulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Urogenital Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Urogenital Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Urogenital Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Dermatology Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Dermatology Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Dermatology Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Acne Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Acne Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Acne Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Atopic Dermatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Atopic Dermatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Atopic Dermatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Neurologic and Gut Brain Axis Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Neurologic and Gut Brain Axis Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Neurologic and Gut Brain Axis Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Europe Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Europe Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 125. Europe Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 126. Europe Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 127. Europe Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 128. Europe Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 129. Europe Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Europe Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 131. Europe Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 132. Europe Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 133. Europe Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. North America Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. North America Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 147. North America Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 148. North America Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 149. North America Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 150. North America Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 151. North America Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. North America Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 153. North America Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 154. North America Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 155. North America Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Latin America Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Latin America Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 158. Latin America Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 159. Latin America Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 160. Latin America Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 161. Latin America Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 162. Latin America Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Latin America Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 164. Latin America Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 165. Latin America Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 166. Latin America Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Middle East Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 169. Middle East Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 170. Middle East Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 171. Middle East Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 172. Middle East Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 173. Middle East Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Middle East Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 175. Middle East Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 176. Middle East Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 177. Middle East Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Africa Next-generation Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Africa Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 180. Africa Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 181. Africa Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 182. Africa Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 183. Africa Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 184. Africa Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Africa Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 186. Africa Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 187. Africa Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 188. Africa Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Global Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. NATO Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. NATO Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 192. NATO Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 193. NATO Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 194. NATO Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 195. NATO Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 196. NATO Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. NATO Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 198. NATO Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 199. NATO Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 200. NATO Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. G7 Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. G7 Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 203. G7 Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 204. G7 Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 205. G7 Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 206. G7 Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 207. G7 Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. G7 Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 209. G7 Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 210. G7 Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 211. G7 Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. European Union Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. European Union Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 214. European Union Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 215. European Union Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 216. European Union Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 217. European Union Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 218. European Union Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. European Union Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 220. European Union Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 221. European Union Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 222. European Union Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. BRICS Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. BRICS Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 225. BRICS Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 226. BRICS Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 227. BRICS Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 228. BRICS Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 229. BRICS Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. BRICS Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 231. BRICS Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 232. BRICS Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 233. BRICS Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. ASEAN Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. ASEAN Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 236. ASEAN Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 237. ASEAN Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 238. ASEAN Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 239. ASEAN Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 240. ASEAN Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. ASEAN Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 242. ASEAN Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 243. ASEAN Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 244. ASEAN Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. GCC Next-generation Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. GCC Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 247. GCC Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 248. GCC Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 249. GCC Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 250. GCC Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 251. GCC Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. GCC Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 253. GCC Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 254. GCC Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 255. GCC Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Global Next-generation Probiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. United States Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 258. United States Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 259. United States Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 260. United States Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 261. United States Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 262. United States Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 263. United States Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. United States Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 265. United States Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 266. United States Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 267. United States Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. China Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 269. China Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 270. China Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 271. China Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 272. China Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 273. China Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 274. China Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. China Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 276. China Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 277. China Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 278. China Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. Germany Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 280. Germany Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 281. Germany Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 282. Germany Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 283. Germany Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 284. Germany Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 285. Germany Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. Germany Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 287. Germany Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 288. Germany Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 289. Germany Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Japan Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 291. Japan Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 292. Japan Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 293. Japan Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 294. Japan Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 295. Japan Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 296. Japan Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Japan Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 298. Japan Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 299. Japan Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 300. Japan Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 301. United Kingdom Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 302. United Kingdom Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 303. United Kingdom Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 304. United Kingdom Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 305. United Kingdom Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 306. United Kingdom Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 307. United Kingdom Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. United Kingdom Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 309. United Kingdom Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 310. United Kingdom Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 311. United Kingdom Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. India Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 313. India Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 314. India Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 315. India Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 316. India Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 317. India Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 318. India Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. India Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 320. India Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 321. India Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 322. India Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. France Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 324. France Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 325. France Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 326. France Next-generation Probiotics Market Size, by Mucus-Associated Bacteria, 2017-2032 (USD Million)
TABLE 327. France Next-generation Probiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 328. France Next-generation Probiotics Market Size, by Consumer Age, 2017-2032 (USD Million)
TABLE 329. France Next-generation Probiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. France Next-generation Probiotics Market Size, by Gastrointestinal Disorders, 2017-2032 (USD Million)
TABLE 331. France Next-generation Probiotics Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 332. France Next-generation Probiotics Market Size, by Dermatology, 2017-2032 (USD Million)
TABLE 333. France Next-generation Probiotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 334. South Korea Next-generation Probiotics Market Size, 2017-2032 (USD Million)
TABLE 335. South Korea Next-generation Probiotics Market Size, by Strain Category, 2017-2032 (USD Million)
TABLE 336. South Korea Next-generation Probiotics Market Size, by Anaerobic Gut-Derived Bacteria, 2017-2032 (USD Million)
TABLE 337. South Korea Next-generation P

Companies Mentioned

  • Pendulum Therapeutics, Inc.
  • The Akkermansia Company
  • Metagenics, LLC
  • Evonik Industries AG
  • HealthBiome, Inc.
  • International Flavors & Fragrances Inc.
  • Sacco S.r.l.
  • BiomeBank
  • Syngen Biotech Co., Ltd.
  • BioGaia AB
  • Codeage LLC
  • Maypro Industries, LLC
  • Medikonda Nutrients
  • ENTEROBIOME
  • Creative BioMart, Inc.
  • OptiBiotix Health Plc
  • Winclove B.V.
  • FitBiomics, Inc.
  • KoBioLabs, Inc.
  • TONIQ
  • UpNourish
  • Akkermy LLC
  • Built By Nature
  • DUPONT DE NEMOURS, INC.
  • EnteroBiotix Limited
  • Enterome S.A.
  • Ferring Pharmaceuticals Inc.
  • Fresh Nutrition Inc.
  • Guangzhou Zhiyi Biotech Co., Ltd.
  • inGreens
  • Kaneka Corporation
  • Kendi Labs LLC
  • Lallemand Inc.
  • MaaT Pharma
  • Meiji Co., Ltd.
  • Meteoric Biopharmaceuticals Private Limited
  • MRM Health NV
  • Next Gen Probiotics sp. z o.o. sp. k.
  • Novonesis A S
  • Probi AB
  • Seres Therapeutics, Inc.
  • Suzhou Thankcome Biotech Co., Ltd.
  • Vedanta Biosciences
  • Verb Biotics LLC
  • Vidya Pvt. Ltd.
  • Vita Actives Ltd
  • Vitamatic
  • Yakult Honsha Co., Ltd.
  • ZBiotics Company

Related Topics

Related Reports

Probiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Probiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 210 Pages
  • Global
From
Probiotic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Probiotic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Probiotic Drinks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Probiotic Drinks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Functional Food Probiotics Market Insights, Analysis and Forecast 2026-2031 - Product Image

Functional Food Probiotics Market Insights, Analysis and Forecast 2026-2031

  • Report
  • 93 Pages
  • Global
From
Probiotic Supplements Market by Product Form, Health Application, End User, Distribution Channel, Ingredient, and Region - Global Forecast to 2031 - Product Image

Probiotic Supplements Market by Product Form, Health Application, End User, Distribution Channel, Ingredient, and Region - Global Forecast to 2031

  • Report
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.